Published in Antimicrob Agents Chemother on August 01, 1977
In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin. Antimicrob Agents Chemother (1978) 1.59
In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 1.46
Molecular and phenotypic characterization of penicillinase-producing Neisseria gonorrhoeae from Canadian sources. Antimicrob Agents Chemother (1981) 1.16
High-pressure liquid chromatographic method for determination of rosaramicin in humans. Antimicrob Agents Chemother (1980) 0.90
Research for new antibiotics in the treatment of gonorrhea and nonspecific urethritis. Can Med Assoc J (1978) 0.80
Moxalactam concentrations in human prostatic tissue. Antimicrob Agents Chemother (1983) 0.75
Pharmacokinetics and metabolism of [14C]rosaramicin in dogs. Antimicrob Agents Chemother (1986) 0.75
In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli. Antimicrob Agents Chemother (1978) 0.75
A new Micromonospora-produced macrolide antibiotic, rosamicin. J Antibiot (Tokyo) (1972) 3.12
Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic. J Antibiot (Tokyo) (1972) 3.08
Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin. Antimicrob Agents Chemother (1974) 2.50
Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. Antimicrob Agents Chemother (1976) 2.12
Interstitial fluid and serum antibiotic concentrations. Arch Surg (1972) 1.75
Concentration of antibiotics in renal interstitial fluid: an experimental model. Urol Res (1975) 1.06
Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects. J Pharm Sci (1977) 1.85
Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scand J Urol Nephrol Suppl (1995) 1.83
Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol (1988) 1.59
Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up. Urology (1990) 1.32
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrob Agents Chemother (1987) 1.25
Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother (1977) 1.23
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials. J Urol (1970) 1.18
The importance of the pressure in the prostatic fossa and absorption of irrigating fluid during transurethral resection of the prostate. J Urol (1973) 1.16
3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol (1986) 1.15
Rosamicin in urethral and vaginal secretions and tissues in dogs and rats. Antimicrob Agents Chemother (1977) 1.15
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Antimicrob Agents Chemother (1980) 1.15
Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infect Dis Suppl (1978) 1.14
Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother (1977) 1.11
Analysis of presenting symptoms in prostatism. J Urol (1984) 1.09
Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection. J Urol (1971) 1.08
Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob Agents Chemother (1983) 1.08
Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs. Invest Urol (1979) 1.07
Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother (1979) 1.06
Scrotal herniation of the lower urinary tract. J Urol (1967) 1.05
Route and prophylaxis of ascending bladder infection in male patients with indwelling catheters. J Urol (1972) 1.03
Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics. Antimicrob Agents Chemother (1975) 1.01
Isolation and biological activity of aspidospermine and quebrachamine from an Aspidosperma tree source. J Pharm Biomed Anal (1994) 1.01
Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother (1973) 1.01
Treatment of urinary tract infections with cefotaxime: noncomparative and prospective comparative trials. Rev Infect Dis (1983) 1.00
Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: experimental and clinical studies. Urology (1976) 0.99
Intravenous administration of sodium colistimethate in urinary tract infections. Curr Ther Res Clin Exp (1967) 0.98
High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue. Antimicrob Agents Chemother (1986) 0.98
Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am (1986) 0.97
Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections. Antimicrob Agents Chemother (1978) 0.97
Significance of prostatic weight in prostatism. Urol Int (1983) 0.96
Bacterial prostatitis: new methods of treatment. Urology (1991) 0.92
Experimental lipid A-induced nephritis in the dog. Invest Urol (1975) 0.92
Cefamandole and cefazolin in the therapy of complicated urinary tract infections. J Infect Dis (1978) 0.91
Posttraumatic priapism: successful treatment with autologous clot embolization. AJR Am J Roentgenol (1979) 0.90
The relevance of minimum urethral resistance in prostatism. J Urol (1983) 0.89
Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report. J Urol (1968) 0.89
Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol Int (1995) 0.89
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrob Agents Chemother (1981) 0.89
[Therapy of the acute uncomplicated urinary tract infection]. Urologe A (2006) 0.89
Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol (1981) 0.89
Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol (1989) 0.89
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids. Infection (1991) 0.89
Malignant interstitial cell testicular tumor. Cancer (1973) 0.89
Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. J Urol (1987) 0.88
Prophylactic antibiotics in transurethral prostatectomy. J Urol (1981) 0.87
Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics. J Clin Pharmacol (1974) 0.87
Determination of absorption of irrigating fluid during transurethral resection of the prostate by means of radioisotopes. J Urol (1969) 0.87
Value of postvoid residual urine determination in evaluation of prostatism. Urology (1982) 0.86
Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology (1995) 0.86
Aztreonam concentrations in human prostatic tissue. Antimicrob Agents Chemother (1984) 0.86
Secretion of various antimicrobial substances in dogs with experimental bacterial prostatitis. Urol Res (1977) 0.85
Spontaneous uroflowmetry in prostatism. Urology (1984) 0.85
Transurethral prostatic resection in the treatment of prostatism with high urinary flow. J Urol (1983) 0.85
The significance of uninhibited detrusor contractions in prostatism. J Urol (1985) 0.84
Chronic bacterial prostatitis: theoretical and experimental considerations. Urol Res (1983) 0.83
Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Infection (1974) 0.83
Transurethral resection versus transurethral incision of the prostate. A prospective randomized study. Urol Clin North Am (1990) 0.83
Scanning electron microscopy of normal and malignant human urothelium. Urology (1976) 0.83
Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs. Infection (1979) 0.83
Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin. J Urol (1983) 0.82
Pharmacokinetics of ampicillin and methoxymethyl ester of hetacillin in dogs. J Pharm Sci (1977) 0.82
Antibiotics excretion in canine vaginal and urethral secretions. Invest Urol (1978) 0.82
Infectious complications after instrumentation of urinary tract. Urology (1985) 0.82
Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids. Antimicrob Agents Chemother (1987) 0.82
Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol (1997) 0.82
Short-term cephalosporin prophylaxis in transurethral surgery. Clin Ther (1982) 0.81
Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin. Urology (1977) 0.81
Role of intracellular Ca2+ stores in smooth muscle contractions of the guinea pig vas deferens. Urol Res (1993) 0.81
Prostatic fluid and tissue concentrations of ampicillin after administration of hetacillin ester (BL-P1761). Invest Urol (1976) 0.81
Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine bone. Antimicrob Agents Chemother (1983) 0.81
Double isotope technique in renal function testing in dogs. Invest Urol (1969) 0.80
Continuous infusion urography in unilateral hydronephrosis. J Urol (1975) 0.80
Simultaneous determination of glomerular filtration rate and effective plasma flow by external monitoring of radioisotopes. An experimental study in dogs. Invest Urol (1970) 0.80
Treatment of urinary tract infections with cephalexin. J Urol (1971) 0.80
Amifloxacin distribution in the dog prostate. Prostate (1985) 0.79
Smooth muscle tone regulation in rabbit cavernosal and spongiosal tissue by cyclic AMP- and cyclic GMP-dependent mechanisms. J Urol (1994) 0.79
Determination of the renal plasma flow and tubular mass by means of radioisotopes. Invest Urol (1968) 0.79
Distribution of ciprofloxacin in the dog prostate and various tissues. Urol Res (1984) 0.79
Importance and timing of prophylactic antibiotics in urology with a special reference to growth and kill rates of E. coli in genitourinary organs. J Urol (1982) 0.79
Obstruction of ureter by abnormal right spermatic vein. Urology (1975) 0.79
Reasons for delay of endocrine treatment in cancer of the prostate (until symptomatic metastases occur). Prog Clin Biol Res (1990) 0.79
Co-trimazine distribution in the canine prostate. Infection (1979) 0.78
The ampicillin concentration in prostatic tissue and prostatic fluid. Urol Int (1967) 0.78
The role of antibacterial prophylaxis in urologic surgery. Urology (1985) 0.78
A guinea pig model for study of bladder mast cell function: histamine release and smooth muscle contraction. J Urol (1990) 0.78
The effect of various treatments on renal function during endotoxin shock. An experimental study in dogs. Invest Urol (1972) 0.78
Prostatic tissue and secretion concentrations of rosamicin and erythromycin. Experimental studies in the dog. Invest Urol (1977) 0.78